Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
Ivonne A. Montes‐Mojarro, Julia Steinhilber, Irina Bonzheim, et al.
Cancers (2018) Vol. 10, Iss. 4, pp. 107-107
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

A Review on a Deep Learning Perspective in Brain Cancer Classification
Gopal S. Tandel, Mainak Biswas, O. G. Kakde, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 111-111
Open Access | Times Cited: 380
Lymphomatoid papulosis: an update and review
Sylvia Aidé Martínez‐Cabriales, Stephen R. Walsh, Shachar Sade, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 1, pp. 59-73
Closed Access | Times Cited: 66
The plasticity of biocompatibility
David F. Williams
Biomaterials (2023) Vol. 296, pp. 122077-122077
Open Access | Times Cited: 19
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Suzanne D. Turner, Giorgio Inghirami, Roberto N. Miranda, et al.
American Journal Of Pathology (2019) Vol. 190, Iss. 1, pp. 2-10
Open Access | Times Cited: 45
Assessment of Silicone Particle Migration Among Women Undergoing Removal or Revision of Silicone Breast Implants in the Netherlands
Henry Dijkman, Inca Slaats, Peter Bult
JAMA Network Open (2021) Vol. 4, Iss. 9, pp. e2125381-e2125381
Open Access | Times Cited: 34
Anti-Cancer Potential of a New Derivative of Caffeic Acid Phenethyl Ester Targeting the Centrosome
Catello Giordano, Jonatan Kendler, Maximilian Sexl, et al.
(2025)
Closed Access
Approaches to therapy of relapsed and refractory forms of anaplastic large cell lymphoma in children and adolescents: A review
А. С. Волкова
Journal of Modern Oncology (2025) Vol. 26, Iss. 4, pp. 404-408
Open Access
Anti-Cancer potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the centrosome
Catello Giordano, Jonatan Kendler, Maximilian Sexl, et al.
Redox Biology (2025) Vol. 81, pp. 103582-103582
Open Access
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
Leukemia (2025)
Open Access
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
Anand K. Deva, Suzanne D. Turner, Marshall E. Kadin, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3861-3861
Open Access | Times Cited: 38
Gluteal Implant-Associated Anaplastic Large Cell Lymphoma
José de Arimatéia Mendes, Vinicius A. Mendes Maykeh, Luiz Fernando Frascino, et al.
Plastic & Reconstructive Surgery (2019) Vol. 144, Iss. 3, pp. 610-613
Open Access | Times Cited: 36
Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities
Thomas Tousseyn, Rebecca L. King, Falko Fend, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 207-226
Closed Access | Times Cited: 21
Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma
Rutger C. Melchers, Rein Willemze, Merel van de Loo, et al.
The American Journal of Surgical Pathology (2020) Vol. 44, Iss. 6, pp. 776-781
Open Access | Times Cited: 28
STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK− ALCL
Emma Andersson, Oscar Brück, Till Braun, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 702-702
Open Access | Times Cited: 23
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Caiqin Xie, Xian Li, Hui Zeng, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 23
NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target
Elissa Andraos, Joséphine Dignac, Fabienne Meggetto
Cancers (2021) Vol. 13, Iss. 1, pp. 144-144
Open Access | Times Cited: 18
Brentuximab vedotin in the treatment of CD30+ PTCL
Stefan K. Barta, Jerald Z. Gong, Pierluigi Porcu
Blood (2019) Vol. 134, Iss. 26, pp. 2339-2345
Open Access | Times Cited: 22
Genomics of LGL leukemia and select other rare leukemia/lymphomas
Katharine B. Moosic, Umadevi Paila, Kristine C. Olson, et al.
Best Practice & Research Clinical Haematology (2019) Vol. 32, Iss. 3, pp. 196-206
Open Access | Times Cited: 16
Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review
Bradley Zehr, Kristina Brannock, Rebecca Wyma, et al.
Diagnostic Pathology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
ALK-positive anaplastic large cell lymphoma in adults
Matthew Gromowsky, Christopher R D’Angelo, Matthew A. Lunning, et al.
Faculty Reviews (2023) Vol. 12
Open Access | Times Cited: 5
Breast implant‐associated anaplastic large cell lymphoma, an under‐recognised entity
Ruvini Thashila Gunawardana, Benjamin F. Dessauvagie, Donna Taylor
Journal of Medical Imaging and Radiation Oncology (2019) Vol. 63, Iss. 5, pp. 630-638
Closed Access | Times Cited: 13
ALK-transformed mature T lymphocytes restore early thymus progenitor features
Annabelle Congras, Coralie Hoareau‐Aveilla, Nina Caillet, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6395-6408
Open Access | Times Cited: 12
Minimal Disease Monitoring in Pediatric Non-Hodgkin’s Lymphoma: Current Clinical Application and Future Challenges
Lara Mussolin, Christine Damm‐Welk, Marta Pillon, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1907-1907
Open Access | Times Cited: 11
A Phase 2 study of acimtamig (AFM13) in patients with CD30-positive, relapsed or refractory peripheral T-cell lymphomas
Won Seog Kim, Jake Shortt, Pier Luigi Zinzani, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 1, pp. 65-73
Open Access | Times Cited: 1
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
Olga Goncharova, Nadine Flinner, Julia Bein, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1484-1484
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top